Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapy-associated febrile neutropenia: A pilot study

Annals of Hematology

Volumn 91, Issue 4, 2012, Pages 605-611

  Kwofie, L ^a   Rapoport, B L ^b   Fickl, H ^a   Meyer, P W A ^a   Rheeder, P ^c   Hlope, H ^b   Anderson, R ^a   Tintinger, G R ^c  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b Medical Oncology Centre of Rosebank   (South Africa)

^c UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Febrile neutropenia; Procalcitonin; Soluble TREM 1; Talcott score

Indexed keywords

AMIKACIN; AMPHOTERICIN; CEFEPIME; CEFTRIAXONE; INTERLEUKIN 8; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; VANCOMYCIN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CALCITONIN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 6; MEMBRANE PROTEIN; PROTEIN PRECURSOR; TREM1 PROTEIN, HUMAN;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONFUSION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE COURSE; DRUG HYPERSENSITIVITY; ECG ABNORMALITY; FEBRILE NEUTROPENIA; FEMALE; HEART ARRHYTHMIA; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HYPOTENSION; INFECTION RISK; INTENSIVE CARE UNIT; KIDNEY FAILURE; MALE; PILOT STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; AREA UNDER THE CURVE; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG THERAPY; MIDDLE AGED; NEUTROPENIA; PATHOPHYSIOLOGY;

ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BIOLOGICAL MARKERS; CALCITONIN; DRUG THERAPY; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEUTROPENIA; PILOT PROJECTS; PROTEIN PRECURSORS; RECEPTORS, IMMUNOLOGIC; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84860791079     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1339-4     Document Type: Article

References (29)

1. Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106(10):2258-2266
2. Talcott JA, Finberg R, Mayer RJ et al (1988) The medical course of cancer patients with fever and neutropenia. Arch Int Med 148:2561-2568
3. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, Talcott JA (2000) The multinational association for supportive care in cancer risk-index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038-3051
4. Nakagawa Y, Suzuki K, Masaoka T (2009) Evaluation of the risk factors for febrile neutropenia associated with hematological malignancy. J Infect Chemother 15:174-179
5. Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K (2008) The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 36:396-407
6. Jimeno A, Garcia-Velasso A, del Val O, González-Billalabeitia E, Hernando S, Hernández R, Sánchez-Muňoz A, López-Martin A, Durán I, Robles L, Cortes-Funes H, Paz-Ares L (2004) Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer 100:2462-2469
7. Uys A, Rapoport BL, Fickl H, Meyer PWA, Anderson R (2007) Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6, -8 and -10. Eur J Cancer Care 16:475-483
8. Persson L, Söderquist B, Engervall P, Vikerfors T, Hansson L-O, Tidefelt U (2005) Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Eur J Haematol 74:297-303
9. Massaro KSR, Costa SF, Leone C, Chamone DAF (2007) Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis 7:137. doi:10, 1186/1471-2334-7-137
10. Prat C, Sancho JM, Dominguez J, Xicoy B, Giminez m, Ferra C, Blanco S, Lacoma A, Ribera JM, Aurina V (2008) Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma 49:1752-1761
11. Semeraro M, Thomée C, Rolland E, Le Deley MC, Rosselini D, Troalen F, Amoroso L, Drubel M, Hartmann O (2010) A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin. Pediatr Blood Cancer 54:284-290
12. Schultz MJ, Determann RM (2008) PCT and sTREM-1: the markers of infection in critically-ill patients? Med Sci Monit 14: RA241-RA247
13. Ford JW, McVicar DW (2009) TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 21:1-9
14. Jiyong J, Tiancha H, Wei C, Huahao S (2009) Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis. Intensive Care Med 35:587-595
15. Tejera A, Santolaria F, Diez M-L, Alemán-Valls M-R, Gonzáles- Reimers E, Martínez-Riera A, Milena-Abril A (2007) Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine 38:117-123
16. Lin CH, Ho CC, Yao M, Hsu SC, Yu CJ (2009) sTREM-1 (soluble triggering receptor expressed on myeloid cells-1) as marker indicating infection in patients with neutropenic fever. Am J Respir Crit Care Med 179:A4704
17. Uys A, Rapoport BL, Anderson R (2004) Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer risk-index score. Support Care Cancer 12:555-560
18. Giamarellou H, Giamarellos-Bourboulis EJ, Repoussis P et al (2004) Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicenter study. Clin Microbiol Infect 10:628-633
19. Stryjewski GR, Nylen ES, Bell MJ et al (2005) Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med 6:129-135
20. Porfyridis I, Plachouras D, Karagianni V, Kotanidou A, Papiris SA, Giamarellou H, Giamarellos-Bourboulis EJ (2010) Diagnostic value of triggering receptor expressed on myeloid cells-1 and Creactive protein for patients with lung infiltrates: an observational study. BMC Infect Dis 10:286-295
21. Talcott JA, Whalen A, Clark J et al (1994) Home antibiotic therapy for low risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 12:107-114
22. Lav RC, King SM, Richardson SE (1994) Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics. Pediatr Hematol Oncol 11:417-421
23. Talcott JA, Siegel RD, Finberg R et al (1992) Risk assessment in cancer patients with fever and neutropenia. A prospective, two-center validation of a prediction rule. J Clin Oncol 10:316-322
24. Han YY, Doughty LA, Kofos D, Sasser H, Carcillo JA (2003) Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis. Pediatr Crit Care Med 4:21-25
25. Sarmati L, Beltrame A, Dori L, Maffongelli G, Cudillo L, De Angelis G, Picardi A, Ottaviani L, Cefalo MG, Venditti A, Amadori S, Arcese W, Andreoni M (2010) Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. Am J Hematol 85 (5):380-383
26. Kelso A (1998) Cytokines: principles and prospects. Immunol Cell Biol 76:300-317
27. Yamamura M, Uyemura K, Deans RJ et al (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277-279
28. Hakim H, Flynn PM, Srivastava DK, Knapp KM, Li C, Okuma J, Gaur AH (2010) Risk prediction in pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J 29:53-59
29. Karapanagiotou EM, Pelekanou E, Charpidou A et al (2008) Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies. Anticancer Res 28:1411-1416